An expanded prescribing role for pharmacists - an Australian perspective

Australasian Medical Journal

Volumn 4, Issue 4, 2011, Pages 236-242

  Hoti, Kreshnik ^a   Hughes, Jeffery ^a   Sunderland, Bruce ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Australia; Australian pharmacy; Non medical prescribing; Pharmacist prescribing; Pharmacy clients

Indexed keywords

AUSTRALIA; COMMUNITY; CONSUMER; HEALTH CARE POLICY; HOSPITAL PERSONNEL; HUMAN; PHARMACIST; PRESCRIPTION; REVIEW; ROLE PLAYING; TRAINING;

EID: 79955662628     PISSN: None     EISSN: 18361935     Source Type: Journal    
DOI: 10.4066/AMJ.2011.694     Document Type: Review

References (47)

1. Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and Prescribing Rights: Review of International Developments. J Pharm Pharmaceut Sci 2005; 8:217-25
2. Galt, K. The key to pharmacist prescribing: collaboration. Am J Health Syst Pharm 1995;52:1696-99
3. Pharasi B, Price M, Goldstein S. Act 101 and the pharmacist--is it appropriate for the pharmacist to prescribe? S Afr Med J 1993; 83:822-23
4. Herrier R, Boyce R, Apgar D. Pharmacist managed patient-care services and prescriptive authority in the U.S. Public Health Service. Hosp Formul 1990; 25:67-80
5. Hobson R, Sewell G. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharm World Sci 2006; 28: 76-90
6. Kondro W. Canada's doctors assail pharmacist prescribing. CMAJ 2007; 177:558
7. Pharmacist Prescribing task Force. Prescribing by pharmacists-information paper (2009). Canadian Society of Hospital Pharmacists. 2010; 63: 267-274
8. Doloresco F, Vermeulen LC. Global survey of hospital pharmacy practice. Am J Health Syst Pharm 2009; 66:S13-S19
9. Weeks GR, Marriott JL. Collaborative prescribing: views of SHPA pharmacist members. J Pharm Pract Res 2008; 38:271-5
10. Cooper RJ, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, James V, Lymn J, McIntosh A, Murphy E, Ratcliffe J, Read S, Ward P. Nurse and pharmacist supplementary prescribing in the UK-A thematic review of the literature. Health Policy 2008; 85: 277-292
11. George J, McCaig D, Bond C, Cunningham IS, Diack HL, Stewart D. Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers. Int J Pharm Pract 2007; 15:23-30
12. Shulman R, Jani Y. Comparison of supplementary prescribers' and doctors' compliance with guidelines for drug dosing in haemofiltration on an intensive care unit. Pharm J 2005; 274:492-3
13. Lloyd F, Hughes CM. Pharmacists' and mentors' views on the introduction of pharmacist supplementary prescribing: a qualitative evaluation of views and context. Int J Pharm Pract 2007;15:31-7
14. Baerlocher M, Detsky A. Professional monopolies in medicine. JAMA 2009; 301:858-860
15. McGhan WF, Stimmel GL, Hall TG, Gilman TM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care 1983;21:435-44
16. Guillaume L, Cooper R, Avery A, Mitchell S, Ward P, Anderson C, Bissell P, Hutchinson A, James V, Lymn J, McIntosh A, Murphy E, Ratcliffe J. Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006. J Clin Pharm Ther 2008; 33: 11-6
17. Crown J. Report of the Review of Prescribing, Supply and Administration of Medicines, London, House of Commons, 1999
18. Reeves D. The 2005 Garrod Lecture: The changing access of patients to antibiotics-for better or worse? J Antimicrob Chemother 2007; 59: 333-41
19. Baird A. Independent and supplementary prescribing and PGDs. Nurs Stand 2005;19:51-6
20. Department of Health. Supplementary prescribing by nurses, pharmacists, chiropodists/podiatrists,physiotherapists and radiographers within the NHS in England: a guide for implementation. London: Department of Health, 2005
21. Department of Health. Improving patients' access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England. London. Department of Health, 2006
22. Zellmer W. Collaborative drug therapy management. Am J Health Syst Pharm 1995; 52:1732
23. Hammond RW, Schwartz AH, Campbell MJ, Remington TL, Chuck S, Blair MM, Vassey AM, Rospond RM, Herner SJ, Webb CE. Collaborative drug therapy management by pharmacists-2003. Pharmacother 2003; 23:1210-25
24. Traynor K. Pharmacists outside U.S. inch toward independent prescribing. Am J Health Syst Pharm 2004; 61:1429
25. Status of collaborative drug therapy management in the United States, March 2004. Am J Health Syst Pharm 2004 Aug 1; 61: 1609-10
26. Meyer B, Hill J, Trujillo G. Attaining pharmacist recognition in the United States. Am J Health Syst Pharm 2008; 65:2152-53
27. Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm 2008; 65: 2126-32
28. Pharmacy Council of New Zealand. Pharmacist prescriber scope of practice consultation. Wellington: Pharmacy Council of New Zealand; 2010; [online]: www.pharmacycouncil.org.nz/cms_show_download.php?id=190 (accessed 15 February 2011).
29. Kay O, Bajorek B, Brien J. Pharmacist Prescibing Activities-an Electronic Survey on the Opinion of Australian Pharmacists. J Pharm Pract Res 2005; 36:199-201
30. Hanes C, Bajorek B. Pharmacist Prescribing: Views of Australian Hospital Pharmacists; J Pharm Pract Res 2005; 35:178-80
31. Weeks GR, Marriott J, George J. Australian hospital pharmacists' experiences of a UK non-medical prescribing course. J Pharm Pract Res 2010; 40:187-93
32. Bessell T, Nissen L, Marriott J, Emmerton L. Improving Australians' access to prescription medicines: Development of pharmacy practice models. Final Report. August 2005, Pharmacy Guild of Australia.
33. Hoti K, Sunderland B, Hughes J, Parsons R. An evaluation of Australian pharmacist's attitudes on expanding their prescribing role. Pharm World Sci 2010; 32:610-21
34. Hoti K., 2011. Pharmacist prescribing in Australia. Thesis (PhD). Curtin University
35. Kay OC, Brien J-AE. Pharmacist prescribing: review of the literature. J Pharm Pract Res 2004; 34: 300-04
36. Smalley L. Patients' experiences of pharmacist-led supplementary prescribing in primary care. PharmJ 2006; 276: 567-69
37. Stewart DC et al. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation. Int J Pharm Pract 2009; 17: 89-94
38. Stewart DC et al. Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing. Ann Pharmacother 2009; 43: 1115-21
39. Hobson RJ et al. Pharmacists and nurses as independent prescribers: exploring the patient's perspective. Fam Pract 2010; 27: 110-20
40. Hoti K, Hughes J, Sunderland B. Pharmacy client's attitudes on expanded pharmacist prescribing and the role of agency theory on involved stakeholders. Int J Pharm Pract 2011; 19:5-12
41. Mott DA, Schommer JC, Doucette WR, Kreling DH. Agency theory, drug formularies, and drug product selection: Implications for public policy. J Public Policy Mark 1998; 17: 287-95
42. Plunkett W. Don't forget that pharmacists already prescribe. Aust Pharm 2008; 27:781
43. The Australian Medical Association; Patient safety paramount in medication prescriptions, 2008 Media Releases; [online]: http://www.ama.com.au/node/3358 (accessed 10 February 2011)
44. The Society of Hospital Pharmacists of Australia. Position Statement. National Competencies for the Prescribing of Medicines. Collingwood, Australia. June 2005. [online] http://www.shpa.org.au/lib/pdf/positionstatement/prescribing_jun05.pdf (accessed 10 February 2011)
45. Pharmaceutical Society of Australia. Position Statement. Dispensing by other health professionals; November 2006
46. Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, Lymn J, Murphy E, Ratcliffe J, Ward P. Stakeholders' views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy 2008; 13:215-221.
47. Weiss M, Sutton J, Adams C. Exploring innovations in pharmacy practice: a qualitative evaluation of supplementary prescribing by pharmacists. Bath: Department of Pharmacy and Pharmacology, University of Bath, 2006